Blood thinning drug safety concerns exposed

Blood thinning drug safety concerns exposed

The BMJ describes dabigatran (Pradaxa) as being a “blockbuster anticoagulant,” which is one of a new generation of drugs for stroke prevention in patients with non-valvular atrial fibrillation. These new drugs have been recommended as part of US, UK,...